Key takeaways: GHK-Cu (copper tripeptide-1) is a copper peptide your body already makes
A narrative review concluded that the practice is controversial because there are no standardized dosing protocols and nearly onethird of patients report adverse effects, ranging from mild gastrointestinal symptoms to liver dysfunction and lifethreatening allergic reactions
As of June 2026, CagriSema is not FDA-approved
[7] [9] Patients with a history of oxalate nephrolithiasis (kidney stones) or hyperoxaluria should avoid high-dose vitamin C administration, as ascorbic acid is metabolized to oxalate, which may precipitate stone formation or exacerbate renal impairment
Stockwell BRJP, Friedmann Angeli H, Bayir, et al
Neuroprotective effects of coffee bioactive compounds: a review